AXS-05

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Addressing Dementia Via Agitation-Centered EvaluationNCT03226522AXSMPhase 2, Phase 3Completed2020-04-17Actual
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease AgitationNCT05557409AXSMPhase 3Completed2024-11-21Actual
Assessing Clinical Outcomes in Alzheimer's Disease AgitationNCT04797715AXSMPhase 3Completed2022-11-21Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.